Antibody Drug Conjugates Market Size 2025-2029
The antibody drug conjugates market size is forecast to increase by USD 13.13 billion at a CAGR of 16.8% between 2024 and 2029. The Antibody Drug Conjugates (ADC) market is experiencing robust growth, fueled by the escalating prevalence of cancer and other diseases, technological advancements in ADC development, and increasing investments in pharmaceutical research and development. This expansion is primarily driven by the increasing demand for innovative solutions, advancements in technology, and evolving consumer preferences. As the healthcare industry transitions towards more efficient systems, better accessibility, and higher industry standards, companies In the ADC market are adjusting their strategies accordingly. Prioritizing sustainability and operational efficiency, these companies aim to maintain a competitive edge In the market. The growing prevalence of diseases such as cancer, which require targeted and effective treatment options, is a significant factor driving the growth of the ADC market. ADCs offer a promising solution by combining the specificity of antibodies with the cytotoxic properties of small molecule drugs, making them highly effective in treating various diseases. Technological advancements in ADC development, including improvements in conjugation chemistry, linker design, and antibody engineering, have expanded the market's scope and potential applications.
What will be the size of the market during the forecast period?
Request Free Sample
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Antibody Drug Conjugates Market 2019 - 2023
- Historic Market Size - Data Table on Global Antibody Drug Conjugates Market 2019 - 2023 ($ million)
- 5.2 Technology segment analysis 2019 - 2023
- Historic Market Size - Technology Segment 2019 - 2023 ($ million)
- 5.3 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
- 5.4 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.5 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on the Global Antibody Drug Conjugates Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Technology
- 8.1 Market segments
- Chart on Technology - Market share (2024-2029) (%)
- Data Table on Technology - Market share (2024-2029) (%)
- 8.2 Comparison by Technology
- Chart on Comparison by Technology
- Data Table on Comparison by Technology
- 8.3 Cleavable linker - Market size and forecast (2024-2029)
- Chart on Cleavable linker - Market size and forecast (2024-2029) ($ million)
- Data Table on Cleavable linker - Market size and forecast (2024-2029) ($ million)
- Chart on Cleavable linker - Year-over-year growth (2024-2029) (%)
- Data Table on Cleavable linker - Year-over-year growth (2024-2029) (%)
- 8.4 Non-cleavable linker - Market size and forecast (2024-2029)
- Chart on Non-cleavable linker - Market size and forecast (2024-2029) ($ million)
- Data Table on Non-cleavable linker - Market size and forecast (2024-2029) ($ million)
- Chart on Non-cleavable linker - Year-over-year growth (2024-2029) (%)
- Data Table on Non-cleavable linker - Year-over-year growth (2024-2029) (%)
- 8.5 Linkerless - Market size and forecast (2024-2029)
- Chart on Linkerless - Market size and forecast (2024-2029) ($ million)
- Data Table on Linkerless - Market size and forecast (2024-2029) ($ million)
- Chart on Linkerless - Year-over-year growth (2024-2029) (%)
- Data Table on Linkerless - Year-over-year growth (2024-2029) (%)
- 8.6 Market opportunity by Technology
- Market opportunity by Technology ($ million)
- Data Table on Market opportunity by Technology ($ million)
9 Market Segmentation by Application
- 9.1 Market segments
- Chart on Application - Market share (2024-2029) (%)
- Data Table on Application - Market share (2024-2029) (%)
- 9.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 9.3 Breast cancer - Market size and forecast (2024-2029)
- Chart on Breast cancer - Market size and forecast (2024-2029) ($ million)
- Data Table on Breast cancer - Market size and forecast (2024-2029) ($ million)
- Chart on Breast cancer - Year-over-year growth (2024-2029) (%)
- Data Table on Breast cancer - Year-over-year growth (2024-2029) (%)
- 9.4 Blood cancer - Market size and forecast (2024-2029)
- Chart on Blood cancer - Market size and forecast (2024-2029) ($ million)
- Data Table on Blood cancer - Market size and forecast (2024-2029) ($ million)
- Chart on Blood cancer - Year-over-year growth (2024-2029) (%)
- Data Table on Blood cancer - Year-over-year growth (2024-2029) (%)
- 9.5 Others - Market size and forecast (2024-2029)
- Chart on Others - Market size and forecast (2024-2029) ($ million)
- Data Table on Others - Market size and forecast (2024-2029) ($ million)
- Chart on Others - Year-over-year growth (2024-2029) (%)
- Data Table on Others - Year-over-year growth (2024-2029) (%)
- 9.6 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
10 Market Segmentation by Product
- 10.1 Market segments
- Chart on Product - Market share (2024-2029) (%)
- Data Table on Product - Market share (2024-2029) (%)
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
- 10.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 10.3 Kadcyla - Market size and forecast (2024-2029)
- Chart on Kadcyla - Market size and forecast (2024-2029) ($ million)
- Data Table on Kadcyla - Market size and forecast (2024-2029) ($ million)
- Chart on Kadcyla - Year-over-year growth (2024-2029) (%)
- Data Table on Kadcyla - Year-over-year growth (2024-2029) (%)
- 10.4 Enhertu - Market size and forecast (2024-2029)
- Chart on Enhertu - Market size and forecast (2024-2029) ($ million)
- Data Table on Enhertu - Market size and forecast (2024-2029) ($ million)
- Chart on Enhertu - Year-over-year growth (2024-2029) (%)
- Data Table on Enhertu - Year-over-year growth (2024-2029) (%)
- 10.5 Adcetris - Market size and forecast (2024-2029)
- Chart on Adcetris - Market size and forecast (2024-2029) ($ million)
- Data Table on Adcetris - Market size and forecast (2024-2029) ($ million)
- Chart on Adcetris - Year-over-year growth (2024-2029) (%)
- Data Table on Adcetris - Year-over-year growth (2024-2029) (%)
- 10.6 Padcev - Market size and forecast (2024-2029)
- Chart on Padcev - Market size and forecast (2024-2029) ($ million)
- Data Table on Padcev - Market size and forecast (2024-2029) ($ million)
- Chart on Padcev - Year-over-year growth (2024-2029) (%)
- Data Table on Padcev - Year-over-year growth (2024-2029) (%)
- 10.7 Trodelvy - Market size and forecast (2024-2029)
- Chart on Trodelvy - Market size and forecast (2024-2029) ($ million)
- Data Table on Trodelvy - Market size and forecast (2024-2029) ($ million)
- Chart on Trodelvy - Year-over-year growth (2024-2029) (%)
- Data Table on Trodelvy - Year-over-year growth (2024-2029) (%)
- 10.8 Polivy - Market size and forecast (2024-2029)
- Chart on Polivy - Market size and forecast (2024-2029) ($ million)
- Data Table on Polivy - Market size and forecast (2024-2029) ($ million)
- Chart on Polivy - Year-over-year growth (2024-2029) (%)
- Data Table on Polivy - Year-over-year growth (2024-2029) (%)
- 10.9 Others - Market size and forecast (2024-2029)
- Chart on Others - Market size and forecast (2024-2029) ($ million)
- Data Table on Others - Market size and forecast (2024-2029) ($ million)
- Chart on Others - Year-over-year growth (2024-2029) (%)
- Data Table on Others - Year-over-year growth (2024-2029) (%)
11 Market Segmentation by Target
- 11.1 Market segments
- Chart on Target - Market share (2024-2029) (%)
- Data Table on Target - Market share (2024-2029) (%)
- 11.2 Comparison by Target
- Chart on Comparison by Target
- Data Table on Comparison by Target
- 11.3 HER2 - Market size and forecast (2024-2029)
- Chart on HER2 - Market size and forecast (2024-2029) ($ million)
- Data Table on HER2 - Market size and forecast (2024-2029) ($ million)
- Chart on HER2 - Year-over-year growth (2024-2029) (%)
- Data Table on HER2 - Year-over-year growth (2024-2029) (%)
- 11.4 CD22 - Market size and forecast (2024-2029)
- Chart on CD22 - Market size and forecast (2024-2029) ($ million)
- Data Table on CD22 - Market size and forecast (2024-2029) ($ million)
- Chart on CD22 - Year-over-year growth (2024-2029) (%)
- Data Table on CD22 - Year-over-year growth (2024-2029) (%)
- 11.5 CD30 - Market size and forecast (2024-2029)
- Chart on CD30 - Market size and forecast (2024-2029) ($ million)
- Data Table on CD30 - Market size and forecast (2024-2029) ($ million)
- Chart on CD30 - Year-over-year growth (2024-2029) (%)
- Data Table on CD30 - Year-over-year growth (2024-2029) (%)
- 11.6 Others - Market size and forecast (2024-2029)
- Chart on Others - Market size and forecast (2024-2029) ($ million)
- Data Table on Others - Market size and forecast (2024-2029) ($ million)
- Chart on Others - Year-over-year growth (2024-2029) (%)
- Data Table on Others - Year-over-year growth (2024-2029) (%)
- 11.7 Market opportunity by Target
- Market opportunity by Target ($ million)
- Data Table on Market opportunity by Target ($ million)
12 Customer Landscape
- 12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
- 13.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- 13.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 13.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 13.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 13.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 13.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 13.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 13.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 13.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 13.10 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 13.11 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 13.12 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 13.13 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 13.14 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 13.15 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 13.16 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 13.17 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
14 Drivers, Challenges, and Opportunity/Restraints
- 14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 14.4 Market opportunities/restraints
15 Competitive Landscape
- 15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 15.3 Landscape disruption
- Overview on factors of disruption
- 15.4 Industry risks
- Impact of key risks on business
16 Competitive Analysis
- 16.2 Market positioning of companies
- Matrix on companies position and classification
- 16.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key offerings
- 16.4 ADC Therapeutics SA
- ADC Therapeutics SA - Overview
- ADC Therapeutics SA - Product / Service
- ADC Therapeutics SA - Key offerings
- 16.5 Adcendo ApS
- Adcendo ApS - Overview
- Adcendo ApS - Product / Service
- Adcendo ApS - Key offerings
- 16.6 Araris Biotech AG
- Araris Biotech AG - Overview
- Araris Biotech AG - Product / Service
- Araris Biotech AG - Key offerings
- 16.7 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- 16.8 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key offerings
- 16.9 Daiichi Sankyo Co. Ltd.
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Product / Service
- Daiichi Sankyo Co. Ltd. - Key offerings
- 16.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Product / Service
- F. Hoffmann La Roche Ltd. - Key offerings
- 16.11 Gilead Sciences Inc.
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key offerings
- 16.12 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Product / Service
- Merck KGaA - Key offerings
- 16.13 Mersana Therapeutics Inc.
- Mersana Therapeutics Inc. - Overview
- Mersana Therapeutics Inc. - Product / Service
- Mersana Therapeutics Inc. - Key offerings
- 16.14 Mythic Therapeutics
- Mythic Therapeutics - Overview
- Mythic Therapeutics - Product / Service
- Mythic Therapeutics - Key offerings
- 16.15 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key offerings
- 16.16 Piramal Enterprises Ltd.
- Piramal Enterprises Ltd. - Overview
- Piramal Enterprises Ltd. - Product / Service
- Piramal Enterprises Ltd. - Key offerings
- 16.17 PPF Group
- PPF Group - Overview
- PPF Group - Product / Service
- PPF Group - Key offerings
- 16.18 Regeneron Pharmaceuticals Inc.
- Regeneron Pharmaceuticals Inc. - Overview
- Regeneron Pharmaceuticals Inc. - Product / Service
- Regeneron Pharmaceuticals Inc. - Key offerings
- 16.19 Seagen Inc.
- Seagen Inc. - Overview
- Seagen Inc. - Product / Service
- Seagen Inc. - Key offerings
- 16.20 Syngene International Ltd.
- Syngene International Ltd. - Overview
- Syngene International Ltd. - Product / Service
- Syngene International Ltd. - Key offerings
- 16.21 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- 16.22 ImmunoGen Inc.
- ImmunoGen Inc. - Overview
- ImmunoGen Inc. - Product / Service
- ImmunoGen Inc. - Key offerings
- 16.23 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Product / Service
- GlaxoSmithKline Plc - Key offerings
- 16.24 Byondis
- Byondis - Overview
- Byondis - Product / Service
- Byondis - Key offerings
- 16.25 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key offerings
- 16.26 ADC Therapeutics SA
- ADC Therapeutics SA - Overview
- ADC Therapeutics SA - Product / Service
- ADC Therapeutics SA - Key offerings
- 16.27 Adcendo ApS
- Adcendo ApS - Overview
- Adcendo ApS - Product / Service
- Adcendo ApS - Key offerings
- 16.28 Araris Biotech AG
- Araris Biotech AG - Overview
- Araris Biotech AG - Product / Service
- Araris Biotech AG - Key offerings
- 16.29 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- 16.30 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key offerings
- 16.31 Daiichi Sankyo Co. Ltd.
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Product / Service
- Daiichi Sankyo Co. Ltd. - Key offerings
- 16.32 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Product / Service
- F. Hoffmann La Roche Ltd. - Key offerings
- 16.33 Gilead Sciences Inc.
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key offerings
- 16.34 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Product / Service
- Merck KGaA - Key offerings
- 16.35 Mersana Therapeutics Inc.
- Mersana Therapeutics Inc. - Overview
- Mersana Therapeutics Inc. - Product / Service
- Mersana Therapeutics Inc. - Key offerings
- 16.36 Mythic Therapeutics
- Mythic Therapeutics - Overview
- Mythic Therapeutics - Product / Service
- Mythic Therapeutics - Key offerings
- 16.37 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key offerings
- 16.38 Piramal Enterprises Ltd.
- Piramal Enterprises Ltd. - Overview
- Piramal Enterprises Ltd. - Product / Service
- Piramal Enterprises Ltd. - Key offerings
- 16.39 PPF Group
- PPF Group - Overview
- PPF Group - Product / Service
- PPF Group - Key offerings
- 16.40 Regeneron Pharmaceuticals Inc.
- Regeneron Pharmaceuticals Inc. - Overview
- Regeneron Pharmaceuticals Inc. - Product / Service
- Regeneron Pharmaceuticals Inc. - Key offerings
- 16.41 Seagen Inc.
- Seagen Inc. - Overview
- Seagen Inc. - Product / Service
- Seagen Inc. - Key offerings
- 16.42 Syngene International Ltd.
- Syngene International Ltd. - Overview
- Syngene International Ltd. - Product / Service
- Syngene International Ltd. - Key offerings
- 16.43 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key offerings
17 Appendix
- 17.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 17.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 17.4 Research methodology
- 17.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 17.9 360 degree market analysis
- 360 degree market analysis
- 17.10 List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
